Sophie Trefely has been a group leader at Â鶹ÊÓƵ since January 2022. She completed her PhD training researching insulin action with David James at the Garvan Â鶹ÊÓƵ of Medical Research, Sydney in 2015. Her post-doctoral training focussed on metabolite signalling and was jointly between the labs of Kathryn Wellen and Nathaniel Snyder, at the University of Pennsylvania.